| Literature DB >> 35436888 |
Fiona de Londras1, Amanda Cleeve2,3, Maria I Rodriguez4, Alana Farrell5, Magdalena Furgalska6, Antonella F Lavelanet3.
Abstract
Many components of abortion care in early pregnancy can safely be provided on an outpatient basis by mid-level providers or by pregnant people themselves. Yet, some states impose non-evidence-based provider restrictions, understood as legal or regulatory restrictions on who may provide or manage all or some aspects of abortion care. These restrictions are inconsistent with the World Health Organization's support for the optimization of the roles of various health workers, and do not usually reflect evidence-based determinations of who can provide abortion. As a matter of international human rights law, states should ensure that the regulation of abortion is evidence-based and proportionate, and disproportionate impacts must be remedied. Furthermore, states are obliged take steps to ensure women do not have to undergo unsafe abortion, to reduce maternal morbidity and mortality, and to effectively protect women and girls from the physical and mental risks associated with unsafe abortion. States must revise their laws to ensure this. Where laws restrict those with the training and competence to provide from participating in abortion care, they are prima facie arbitrary and disproportionate and thus in need of reform. This review, developed by experts in reproductive health, law, policy, and human rights, examined the impact of provider restrictions on people seeking abortion, and medical professionals. The evidence from this review suggests that provider restrictions have negative implications for access to quality abortion, contributing inter alia to delays and recourse to unsafe abortion. A human rights-based approach to abortion regulation would require the removal of overly restrictive provider restrictions. The review provides evidence that speaks to possible routes for regulatory reform by expanding the health workforce involved in abortion-related care, as well as expanding health workers' roles, both of which could improve timely access to first trimester surgical and medical abortion, reduce costs, save time, and reduce the need for travel.Entities:
Keywords: Abortion; Abortion law and policy; Human rights; Law and policy; Provider restrictions; Reproductive health
Mesh:
Year: 2022 PMID: 35436888 PMCID: PMC9014563 DOI: 10.1186/s12978-022-01405-x
Source DB: PubMed Journal: Reprod Health ISSN: 1742-4755 Impact factor: 3.355
Impact of PR on the abortion seeker (A + B + C)
| Outcome | Overall conclusion of evidence (A) | Application of HR standards (B) | Conclusion evidence + HR (C) |
|---|---|---|---|
| Delayed abortion | Overall, evidence from three studies suggests that provider restrictions may result in delayed abortions One study indirectly examines provider restrictions on delayed abortion by demonstrating how expansion of health worker roles (and thereby reducing provider restrictions) improve timely access to first trimester surgical and medical abortion Evidence from two studies suggests that government mandated abortion counselling increases the administrative and logistical burdens for providers and women, and may increase abortion delays | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by taking steps to reduce maternal mortality and morbidity including addressing unsafe abortion, and by ensuring abortion regulation is evidence-based and proportionate) | Delayed access to abortion care can have negative impacts on the right to life, health, and to physical and mental integrity. Provider restrictions that are not justified by evidence (e.g., of competence, effectiveness, acceptability) interfere disproportionately with rights |
| Continuation of pregnancy | No evidence identified | Provider restrictions engage states’ obligations to protect, respect and fulfil the right to health (by ensuring abortion regulation is evidence-based and proportionate) and the right to decide on the number and spacing of children. They may also result in violations of the state’s obligation to ensure abortion is available where the life and health of the pregnant person is at risk, or where carrying a pregnancy to term would cause her substantial pain or suffering, including where the pregnancy is the result of rape or incest or where the pregnancy is not viable | If provider restrictions not based in evidence result in undesired continuation of pregnancy, this has negative impacts for rights to health, physical and mental integrity, privacy, and potentially the right to be free from torture, inhuman and degrading treatment or punishment |
| Opportunity costs | Overall evidence from seven studies suggests that provider restrictions increase opportunity costs for abortion seekers Provider restrictions may be linked to opportunity costs such as increased financial costs, need for travel, waiting times, additional clinic contacts, emotional distress, and undesired surgical interventions | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by ensuring where it is lawful, abortion is safe and accessible, by ensuring abortion regulation is evidence-based and proportionate), and the right to equality and non-discrimination | Provider restrictions that are not justified by evidence (e.g., of competence, effectiveness, acceptability) interfere disproportionately with rights to health and to physical and mental integrity. Provider restrictions can particularly affect marginalized women and women in rural areas with negative implications for their right to equality and non-discrimination in access to healthcare |
| Unlawful abortion | No evidence identified | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by taking steps to reduce maternal mortality and morbidity including addressing unsafe abortion, and by protecting people seeking abortion) | If provider restrictions not based in evidence result in inaccessibility of lawful abortion and recourse to unlawful abortion, which may be unsafe, this has negative impacts for rights to health, physical and mental integrity, and privacy |
| SMA | Overall evidence from one study suggests that provider restrictions, when they limit access to care, may be linked to unsafe self-managed abortion | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by taking steps to reduce maternal mortality and morbidity including addressing unsafe abortion, by ensuring abortion regulation is evidence-based and proportionate, and by protecting people seeking abortion) | Where provider restrictions lead abortion seekers to self-manage their abortions outside the formal health system, and where such self-managed abortion is unsafe, the provider restrictions have negative implications for rights |
| Referral to another provider | No evidence identified | N/A | Where provider restrictions preclude a healthcare provider from providing abortion care, immediate referral to a qualified and willing provider may ensure lawful abortion is safe and accessible for the abortion seeker |
Impact of PR on the abortion provider (A + B + C)
| Outcome | Overall conclusion of evidence (A) | Application of HR standards (B) | Conclusion evidence + HR (C) |
|---|---|---|---|
| Workload implications | Overall evidence from six studies suggests that provider restrictions have workload implications Four of the five studies examined this indirectly, by demonstrating the benefit in task sharing abortion care with health workers who are not physicians. One study directly examined workload implications from provider restrictions with mandated counselling All studies reported that provider restrictions may be linked with a range of workload implications including issues surrounding sustainability of staffing, logistical and financial costs, organizational changes, increased workload and stress among providers | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by ensuring abortion regulation is evidence-based and proportionate, and by protecting healthcare professionals providing abortion care) | Workload implications arising from provider restrictions that are not justified by evidence (e.g., of competence, effectiveness, acceptability) may place significant burdens on healthcare professionals providing abortion care, with negative implications for both their rights and the rights of persons seeking to access abortion |
| System costs | Overall, evidence from five papers suggests that provider restrictions contribute to increased system costs Provider restrictions contribute to costs at the individual, provider and systems level. For individuals, these costs are typically associated with increased time in obtaining care. At the provider and system level, provider restrictions may be associated with system inefficiencies that increase administrative burden, workload and staff time | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by ensuring abortion regulation is evidence-based and proportionate, and by ensuring that where it is lawful abortion is safe and accessible) | Provider restrictions are linked with system costs. Where these restrictions are not justified by evidence (e.g., of competence, effectiveness, acceptability) they interfere disproportionately with rights to health and to physical and mental integrity |
| Perceived imposition on personal ethics or conscience | Overall, evidence from one study suggests that provider restrictions by means of mandated counselling may have a perceived imposition on providers’ personal ethics or conscience | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by ensuring abortion regulation is evidence-based and proportionate, and by protecting healthcare professionals providing abortion care) | Provider restrictions that are not justified by evidence (e.g., of competence, effectiveness, acceptability) may interfere with the right of healthcare providers to thought, conscience or belief by prohibiting them conscientiously from providing abortion care and reducing or hindering access to lawful abortion |
| Perceived impact on relationship with patient | Overall, evidence from one study suggests that provider restrictions by means of mandated counselling are perceived by some providers to have a negative impact on the provider-patient relationship | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by ensuring abortion regulation is evidence-based and proportionate, and by protecting healthcare professionals providing abortion care) | Provider restrictions that are not justified by evidence (e.g., of competence, effectiveness, acceptability) interfere disproportionately with rights to health and to physical and mental integrity |
| Stigmatization | No evidence identified | Provider restrictions engage states’ obligation to respect, protect and fulfil rights to life and health (by protecting healthcare professionals providing abortion care) | Provider restrictions may intensify or exacerbate abortion-related stigma for healthcare providers permitted to provide abortion care. Stigma may result in decisions to opt out of or minimize abortion care provision, with consequences for the availability of lawful abortion |
Fig. 1PRISMA Flow diagram
Characteristics of included studies
| Author/year | Country | Methods | Participants | Applicable Provider Restriction |
|---|---|---|---|---|
| Afework 2015 | Ethiopia | Individual interviews at three private health facilities | Women seeking abortion services n = 38, health extension workers n = 9, healthcare providers n = 7 | No provider restrictions in legislation; determined by ministerial guidelines. Elements of CAC may be provided by gynecologists, General Practitioners (GPs), health officers, IESO and nurse midwives, nurses and health extension workers |
| Andersen 2016 | Nepal | Program evaluation including baseline and post-training evaluation using provider progress reports and interviews | N = 290 primary level facilities providing medical abortion. Interviews with 98 healthcare providers | Provision of medical abortion expanded from physicians and staff nurses to auxiliary nurse-midwives already certified as skilled birth attendants |
| Battistelli 2018 | United States | Individual interviews | Administrators n = 20 whose 5 organizations trained and employed healthcare providers in surgical abortion | Provision of first-trimester aspiration abortions extended to nurse practitioners, certified nurse-midwives, and physician assistants |
| Bridgman-Packer 2018 | Ethiopia | Case study including a desk review and individual interviews | Healthcare providers n = 3, government officials n = 1, NGO staff n = 4 | No provider restrictions in legislation; determined by ministerial guidelines. Elements of CAC may be provided by gynecologists, GPs, health officers, IESO and nurse midwives, nurses and health extension workers |
| De Moel-Mandel 2019 | Australia (Victoria) | Delphi process | Healthcare providers n = 17, experts involved with or interested in medical abortion provision Of 24 participants 17 completed 3 rounds | Prescription for medication abortion only permitted by physicians who have completed a particular online training program |
| Grossman 2015 | United States and Australia | Legal commentary | N/A | Prescription for mifepristone limited to certified physicians (GPs who have completed online training, or obstetrician-gynecologists exempt from the online training) |
| Mercier 2015 | North Carolina, United States | In-depth individual interviews | Abortion providers (17 physicians, 9 nurses, 1 physician assistant, 1 counsellor and 3 clinic administrators) | Women´s Right to Know Act (WRTK) which mandates that counselling is conducted by licensed medical professionals |
| Rasmussen 2021 | Illinois, United States | In-depth interviews | 19 primary care clinicians and administrators (7 family physicians, 3 nurse practitioners, 4 certified nurse midwives, 5 administrators) | Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for mifespristone, which requires providers to be certified with the manufacturer and complete a Prescriber Agreement Form, patients to sign a Patient Agreement Form, and medication to be dispensed only in a clinical, medical office or hospital |
| Srinivasulu 2021 | United States | Online qualitative surveys | 113 primary care clinicians (67 family physicians, 17 midwives, 12 nurse practitioners or physician assistants, 9 other physician types, 8 no response) | Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for mifespristone, which requires providers to be certified with the manufacturer and complete a Prescriber Agreement Form, patients to sign a Patient Agreement Form, and medication to be dispensed only in a clinical, medical office or hospital |